A feasibility study of adjuvant therapy with FOLFOX plus Ca/Mg for the patient with colorectal cancer
Ontology highlight
ABSTRACT: Interventions: FOLFOX4(L-OHP85mg/m2,l-LV100mg/m2x2, 5FU400mg/m2(bolus)x2, 5FU600mg/m2x2(civ)) or mFOLFOX6(L-OHP85mg/m2, l-LV200mg/m2, 5FU400mg/m2(bolus), 5FU2400mg/m2(civ)). Ca/Mg 0.8-1g (iv) x2 before and after L-OHP infusion Cycles of therapy are given every 2 weeks for 12 cycles
Primary outcome(s): the rate of completion of treatment as planned
Study Design: Single arm Non-randomized
DISEASE(S): Colorectal Cancer
PROVIDER: 2619165 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA